HANDOK Inc. (KRX:002390)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,150
-320 (-2.79%)
At close: Feb 27, 2026
-6.69%
Market Cap 144.85B
Revenue (ttm) 516.37B
Net Income (ttm) -43.54B
Shares Out 12.99M
EPS (ttm) -3,162.37
PE Ratio n/a
Forward PE n/a
Dividend 200.00 (1.79%)
Ex-Dividend Date Feb 26, 2026
Volume 37,720
Average Volume 30,376
Open 11,320
Previous Close 11,470
Day's Range 11,100 - 11,320
52-Week Range 10,500 - 14,250
Beta 0.40
RSI 44.52
Earnings Date Feb 6, 2026

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The co... [Read more]

Sector Healthcare
Founded 1954
Employees 940
Stock Exchange Korea Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2024, HANDOK's revenue was 507.36 billion, a decrease of -2.94% compared to the previous year's 522.74 billion. Losses were -52.56 billion, 82.5% more than in 2023.

Financial Statements

News

There is no news available yet.